Chronic Pain - FDA Approves New Pain Patch: Butrans
Links shared publicly online about this topic.
- 835total visits
Chronic Pain - FDA Approves New Pain Patch: Butrans
The FDA has approved Butrans" (buprenorphine) Transdermal System CIII for the management of moderate to severe chronic pain in patients requiring a continuous, around-the-clock opioid analgesic for an extended period of time.
View full resource at healthcentral.com
Tags: Pain, Chronic Pain, FDA, Analgesic Medication, Butrans
Most Recently Shared on September 30, 2010 at 9:49 pm By:
Chronic Pain - FDA Approves New Pain Patch: Butrans http://t.co/OhZlR0p via @AddThis
BUTRANS - New Product Releases - MPR
empr.com — “Moderate to severe chronic pain when continuous opioid analgesia is needed for extended time period. Not for as-needed use.” View full resource at empr.com
Most Recently Shared on January 7, 2011 at 2:31 pm By:
MPR News: BUTRANS: Buprenorphine 5mcg/hour, 10mcg/hour, 20mcg/hour; transdermal patch. http://bit.ly/hl0PvK
Advertisement
